Bank of Montreal’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,411
Closed -$321K 4037
2024
Q2
$321K Buy
+28,411
New +$353K ﹤0.01% 2683
2021
Q2
Sell
-47
Closed -$7K 4256
2021
Q1
$7K Sell
47
-111
-70% -$18.8K ﹤0.01% 4518
2020
Q4
$27K Buy
158
+61
+63% +$11K ﹤0.01% 4283
2020
Q3
$18K Buy
97
+70
+259% +$11.5K ﹤0.01% 3880
2020
Q2
$3K Buy
+27
New +$2.75K ﹤0.01% 4483
2020
Q1
Hold
0
4366
2019
Q2
Sell
-13
Closed -$39K 4972
2019
Q1
$39K Buy
13
+12
+1,200% +$1.05K ﹤0.01% 3435
2018
Q4
$0 Sell
1
-10
-91% -$1.17K ﹤0.01% 4747
2018
Q3
$1K Buy
11
+10
+1,000% +$26.1K ﹤0.01% 4542
2018
Q2
$1K Sell
1
-49
-98% -$113K ﹤0.01% 4538
2018
Q1
$136K Hold
50
﹤0.01% 2827
2017
Q4
$118K Buy
+50
New +$111K ﹤0.01% 2940
2016
Q2
Sell
-1
Closed -$3K 4197
2016
Q1
$3K Hold
1
﹤0.01% 3913
2015
Q4
$4K Buy
+1
New +$3.26K ﹤0.01% 3851

Other funds holding IMUX

Bank of Montreal's IMUX Position: Q3 2024 in Review

Bank of Montreal sold out of Immunic (IMUX) in Q3 2024, closing a stake of 28,411 shares — an estimated $321K sold.

Bank of Montreal first reported a position in IMUX in Q4 2015 and held it in 13 quarters. The position peaked at $321K in Q2 2024. 61 funds tracked by Wall St. Rank hold IMUX as of Q3 2024.

  • Bank of Montreal reported no remaining Immunic position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 28,411 Immunic shares in Q3 2024, an estimated $321K.
  • Bank of Montreal first reported a position in Immunic in Q4 2015 and held it in 13 quarters.
  • Bank of Montreal's Immunic position peaked at $321K in Q2 2024.
  • 61 funds tracked by Wall St. Rank held Immunic as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.